AAAAAA

   
Results: 1-25 | 26-50 | 51-56 |
Results: 51-56/56

Authors: Wang, PY Gullen, B Newton, MG Cheng, YC Schinazi, RF Chu, CK
Citation: Py. Wang et al., Asymmetric synthesis and antiviral activities of L-carbocyclic 2 ',3 '-didehydro-2 ',3 '-dideoxy and 2 ',3 '-dideoxy nucleosides, J MED CHEM, 42(17), 1999, pp. 3390-3399

Authors: Hart, CE Lennox, JL Pratt-Palmore, M Wright, TC Schinazi, RF Evans-Strickfaden, T Bush, TJ Schnell, C Conley, LJ Clancy, KA Ellerbrock, TV
Citation: Ce. Hart et al., Correlation of human immunodeficiency virus type 1 RNA levels in blood andthe female genital tract, J INFEC DIS, 179(4), 1999, pp. 871-882

Authors: Pillay, D Schinazi, RF
Citation: D. Pillay et Rf. Schinazi, Antiviral drug resistance: From the laboratory to the patient, ANTIVIR TH, 3(4), 1998, pp. 237-237

Authors: Hurwitz, SJ Tennant, BC Korba, BE Gerin, JL Schinazi, RF
Citation: Sj. Hurwitz et al., Pharmacodynamics of (-)-beta-2 ',3 '-dideoxy-3 '-thiacytidine in chronically virus-infected woodchucks compared to its pharmacodynamics in humans (vol 42, pg 2804, 1998), ANTIM AG CH, 42(12), 1998, pp. 3337-3337

Authors: Dagan, S Ilan, E Schinazi, RF
Citation: S. Dagan et al., Hepatitis C and hepatitis B animal models, THERAPIES FOR VIRAL HEPATITIS, 1998, pp. 149-159

Authors: Furman, PA Schinazi, RF
Citation: Pa. Furman et Rf. Schinazi, The mechanism of action and cellular pharmacology of anti-hepatitis B virus agents, THERAPIES FOR VIRAL HEPATITIS, 1998, pp. 273-283
Risultati: 1-25 | 26-50 | 51-56 |